Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
ESC Heart Failure|September 4, 2025
Re-PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patientsMarcin Ufnal, Macarena P Quintana-Hayashi, Kathleen Connolly, et al.Magma (New York, N.Y.)|July 15, 2026
Estimation of skin sodium content via 23Na magnetic resonance imaging at 3 T using a single-loop surface transmit/receive coilJonathan Richard Birchall, Joshua Daniel Kaggie, Frank Riemer, et al.Journal of the American Heart Association|July 26, 2024
Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled StudyKathleen Connolly, Richard George, Sami Omar, et al.ESC Heart Failure|January 20, 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIREMarcin Ufnal, Kathleen Connolly, Marcus Millegard, et al.Molecular Therapy. Advances|May 15, 2026
The first oral relaxin receptor RXFP1 agonist for heart failure treatment: Translational studies from non-human primates to humansErik Ryberg, Fredrik Bergström, Sebastian Sten, et al.Cardiovascular Research|March 4, 2025
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunctionMonika Papworth, Spoorthy Kulkarni, Madeleine Antonsson, et al.Pageof 2